Role of EMT in metastasis and therapy resistance
BN Smith, NA Bhowmick - Journal of clinical medicine, 2016 - mdpi.com
Epithelial–mesenchymal transition (EMT) is a complex molecular program that regulates
changes in cell morphology and function during embryogenesis and tissue development …
changes in cell morphology and function during embryogenesis and tissue development …
The interactivity between TGFβ and BMP signaling in organogenesis, fibrosis, and cancer
F Dituri, C Cossu, S Mancarella, G Giannelli - Cells, 2019 - mdpi.com
The Transforming Growth Factor beta (TGFβ) and Bone Morphogenic Protein (BMP)
pathways intersect at multiple signaling hubs and cooperatively or counteractively …
pathways intersect at multiple signaling hubs and cooperatively or counteractively …
Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks
J Vaquero, N Guedj, A Clapéron… - Journal of …, 2017 - Elsevier
Cholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to its late
clinical presentation and the lack of effective non-surgical therapies. Unfortunately, most of …
clinical presentation and the lack of effective non-surgical therapies. Unfortunately, most of …
COVID-19. Pandemic surgery guidance
Based on high quality surgery and scientific data, scientists and surgeons are committed to
protecting patients as well as healthcare staff and hereby provide this Guidance to address …
protecting patients as well as healthcare staff and hereby provide this Guidance to address …
[HTML][HTML] Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update
Epithelial-to-mesenchymal transition (EMT) represents conversion of an epithelial cell in an
elongated cell with mesenchymal phenotype, which can occur in physiologic and pathologic …
elongated cell with mesenchymal phenotype, which can occur in physiologic and pathologic …
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance
L Fouassier, M Marzioni, MB Afonso… - Liver …, 2019 - Wiley Online Library
Cholangiocarcinoma (CCA) is a deadly disease. While surgery may attain cure in a minor
fraction of cases, therapeutic options in either the adjuvant or advanced setting are limited …
fraction of cases, therapeutic options in either the adjuvant or advanced setting are limited …
[HTML][HTML] BMP signaling and its paradoxical effects in tumorigenesis and dissemination
L Zhang, Y Ye, X Long, P Xiao, X Ren, J Yu - Oncotarget, 2016 - ncbi.nlm.nih.gov
Bone morphogenetic proteins (BMPs) play important roles in embryonic and postnatal
development by regulating cell differentiation, proliferation, motility, and survival, thus …
development by regulating cell differentiation, proliferation, motility, and survival, thus …
Role of cancer stem cells in cholangiocarcinoma and therapeutic implications
HJ Wu, PY Chu - International Journal of Molecular Sciences, 2019 - mdpi.com
Cholangiocarcinoma (CCA) is the second most common type of liver cancer, and is highly
aggressive with very poor prognosis. CCA is classified into intrahepatic cholangiocarcinoma …
aggressive with very poor prognosis. CCA is classified into intrahepatic cholangiocarcinoma …
Epithelial to mesenchymal transition in a clinical perspective
J Pasquier, N Abu-Kaoud, H Al Thani… - Journal of …, 2015 - Wiley Online Library
Tumor growth and metastatic dissemination rely on cellular plasticity. Among the different
phenotypes acquired by cancer cells, epithelial to mesenchymal transition (EMT) has been …
phenotypes acquired by cancer cells, epithelial to mesenchymal transition (EMT) has been …
ZEB2, a master regulator of the epithelial–mesenchymal transition, mediates trophoblast differentiation
STUDY QUESTION Does the upregulation of the zinc finger E-box binding homeobox 2
(ZEB2) transcription factor in human trophoblast cells lead to alterations in gene expression …
(ZEB2) transcription factor in human trophoblast cells lead to alterations in gene expression …